Sihuan (460 HK) Updates on Audit Delay: Improper accounting treatment in consolidation trick of using MRAs (Market Research Agents) to exclude hidden sales and distribution expenses to artificially boost profits April 20, 2015April 20, 2015bambooinnovator Leave a comment Related postings: Late audits halt trading in Morgan Stanley-backed stocks Tianhe Chemicals (1619 HK) and Sihuan Pharmaceutical (460 HK) Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Print (Opens in new window) Print Email a link to a friend (Opens in new window) Email Like Loading... Related
AsianExtractor: Unearthing Accounting Fraud in Asia 